AstraZeneca has come to the public's aid with a new program for preventing heart attacks. It works like this: prescribe the company's statin drug to 500 healthy people, at a cost of $638,000 per year. For that investment, you may avoid one heart attack. While some curmudgeons note that Astra's drug also increases the risk of developing Type 2 diabetes, these critics fail to appreciate that they should shut up. Read here.